Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Study of GSK961081 in Healthy Volunteer Subjects (NCT00887406)Theravance Biopharma2005-11-07
Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch (NCT03785613)Grünenthal GmbH2005-11-07
BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours (NCT02273388)Boehringer Ingelheim2005-11-04
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis (NCT00309660)Herlev Hospital2005-11-01
A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine (NCT01003093)Statens Serum Institut2005-11-01
Oral Ghrelin Agonist in Healthy Subjects (NCT00377377)University Hospital, Basel, Switzerland2005-11-01
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT00283114)Seagen Inc.2005-11-01
Safety Study of Autologous Stem Cell in Liver Cirrhosis (NCT00382278)Universidade Federal do Rio de Janeiro2005-11-01
Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy (NCT00327223)AmpliMed Corporation2005-11-01
Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery (NCT00290719)University of California, San Francisco2005-11-01
Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography (NCT01561924)Novo Nordisk A/S2005-11-01
Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) (NCT00248365)Kiadis Pharma2005-11-01
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens (NCT00294736)OSI Pharmaceuticals2005-11-01
Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Randomised Trial (NCT00214669)Barts & The London NHS Trust2005-11-01
Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00648934)Mylan Pharmaceuticals Inc2005-11-01
Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer (NCT00245024)National Cancer Institute (NCI)2005-11-01
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer (NCT00317434)University of Alabama at Birmingham2005-11-01
V710 First-In-Man (FIM) Study (V710-001) (NCT00303069)Merck Sharp & Dohme LLC2005-11-01
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00243100)National Cancer Institute (NCI)2005-11-01
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer (NCT00459186)Dana-Farber Cancer Institute2005-11-01
A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma (NCT00792012)University of Colorado, Denver2005-11-01
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults (NCT00109746)National Center for Complementary and Integrative Health (NCCIH)2005-11-01
Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers (NCT02253875)Boehringer Ingelheim2005-11-01
0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck (NCT00257738)University of Maryland, Baltimore2005-11-01
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation (NCT00597441)Sumitomo Pharma Switzerland GmbH2005-11-01
A Study of Bitopertin (RO4917838) in Healthy Male Volunteers (NCT01636492)Hoffmann-La Roche2005-11-01
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus (NCT00233935)National Cancer Institute (NCI)2005-11-01
Radiation Therapy in Treating Patients With Liver Metastases (NCT00255814)Radiation Therapy Oncology Group2005-11-01
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies (NCT00256191)Cortice Biosciences, Inc.2005-11-01
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis (NCT00380744)Eli Lilly and Company2005-11-01
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours (NCT01058538)Philogen S.p.A.2005-11-01
Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas (NCT00012974)US Department of Veterans Affairs2005-11-01
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System (NCT00647842)Mylan Pharmaceuticals Inc2005-11-01
Static and Dynamic Balance in Correlation With Quality of Life, in Primary Total Knee Replacement (NCT00256958)Hadassah Medical Organization2005-11-01
Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy (NCT00346853)University of Utah2005-11-01
Is Botox Effective in Relieving Pain From Knee Osteoarthritis? (NCT00279903)Mayo Clinic2005-11-01
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes (NCT01511692)Novo Nordisk A/S2005-11-01
AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation (NCT00252252)ResMed2005-11-01
Levetiracetam 750 mg Tablets Under Non-Fasting Conditions (NCT00849485)Teva Pharmaceuticals USA2005-11-01
Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers (NCT02266537)Boehringer Ingelheim2005-11-01
Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma (NCT00276055)New Mexico Cancer Research Alliance2005-11-01
Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer (NCT02182219)Boehringer Ingelheim2005-11-01
Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors (NCT00503412)AstraZeneca2005-11-01
Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background (NCT00162292)Bristol-Myers Squibb2005-11-01
Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD) (NCT00258778)Protalix2005-11-01
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders (NCT00293410)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2005-11-01
Safety and Efficacy Study of Rituximab in Renal Transplantation (NCT00255593)Karolinska University Hospital2005-11-01
Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg (NCT00649155)Mylan Pharmaceuticals Inc2005-11-01
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder (NCT00135421)Bristol-Myers Squibb2005-11-01
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00290004)Pharmacyclics LLC.2005-11-01
Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00649467)Mylan Pharmaceuticals Inc2005-11-01
Effect of NGX-4010 on ENFD and Sensory Function (NCT00254449)NeurogesX2005-11-01
Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg (NCT00648154)Mylan Pharmaceuticals Inc2005-11-01
Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003) (NCT01011725)Merck Sharp & Dohme LLC2005-11-01
Effectiveness of Three Manual Physical Therapy Techniques in a Subgroup of Patients With Low Back Pain (NCT00257998)Franklin Pierce University2005-11-01
Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer (NCT00243854)Indiana University2005-11-01
Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia (NCT00345826)Jonsson Comprehensive Cancer Center2005-11-01
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma (NCT00179725)Celgene Corporation2005-11-01
The Medtronic RESOLUTE Clinical Trial (NCT00248079)Medtronic Vascular2005-11-01
Vaccine Treatment for Surgically Resected Pancreatic Cancer (NCT00255827)NewLink Genetics Corporation2005-11-01
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions (NCT00865033)Sandoz2005-11-01
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females (NCT00254800)AstraZeneca2005-11-01
Evaluation of a Balance-recovery Specific Falls Prevention Exercise Program (NCT00187317)Sunnybrook Health Sciences Centre2005-11-01
Comparison of Two Insulin Detemir Formulations in Healthy Volunteers (NCT01498926)Novo Nordisk A/S2005-11-01
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus (NCT00124800)Tinnitus Research Consortium2005-11-01
Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention (NCT00947635)University of Alberta2005-11-01
Local Anaesthetic Effects of Transcutaneous Amitriptyline (NCT00355277)University Hospital, Clermont-Ferrand2005-11-01
Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers (NCT02253849)Boehringer Ingelheim2005-11-01
MGA031, Sirolimus and Tacrolimus in Islet Transplantation (NCT00265473)University of Minnesota2005-11-01
Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors (NCT00511849)Pfizer2005-11-01
Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT01803321)Regeneron Pharmaceuticals2005-11-01
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers (NCT00730782)European Vaccine Initiative2005-11-01
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674)Masonic Cancer Center, University of Minnesota2005-11-01
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities (NCT00311649)National Institute of Allergy and Infectious Diseases (NIAID)2005-11-01
Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00649740)Mylan Pharmaceuticals Inc2005-11-01
Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors (NCT00257881)Wyeth is now a wholly owned subsidiary of Pfizer2005-11-01
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer (NCT00290732)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2005-11-01
Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) (NCT00261365)Bristol-Myers Squibb2005-11-01
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00310024)National Cancer Institute (NCI)2005-11-01
A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery (NCT00246779)Ottawa Heart Institute Research Corporation2005-11-01
Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers (NCT00214461)Sanofi2005-11-01
Effect of Vitamin D and Calcium on Genes in the Colon (NCT00298545)Rockefeller University2005-11-01
Effect of Glutamine on Intestinal Permeability in Crohn's Disease (NCT00838149)All India Institute of Medical Sciences2005-11-01
A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions (NCT00864071)Actavis Inc.2005-11-01
The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress (NCT00250185)National Heart, Lung, and Blood Institute (NHLBI)2005-11-01
Safety Study of ECO Conversion System For Red Blood Cells. (NCT00261274)Velico Medical2005-11-01
ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT00132379)Active Biotech AB2005-11-01
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas (NCT00751270)Candel Therapeutics, Inc.2005-11-01
Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects (NCT00864500)Actavis Inc.2005-11-01
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer (NCT00253318)M.D. Anderson Cancer Center2005-11-01
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I (NCT00215527)Patricia I. Dickson, M.D.2005-11-01
Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma (NCT00134082)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2005-11-01
Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State (NCT01562457)Novo Nordisk A/S2005-11-01
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis (NCT00275613)Mayo Clinic2005-11-01
Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01515137)University of Pittsburgh2005-11-01
Acupressure and Relaxation for Nausea Control (NCT00243269)University of Rochester2005-11-01
Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate (NCT00915122)University Health Network, Toronto2005-11-01
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy (NCT00473512)Cougar Biotechnology, Inc.2005-11-01
Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients (NCT00260234)Novocell2005-11-01
Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults (NCT00124007)National Institute of Allergy and Infectious Diseases (NIAID)2005-11-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.